United States
Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program
phosphatidylserine, radiation therapy, PD-1, melanoma, immunotherapy, immune modulation
tumor immunology, tumor heterogeneity, Immune checkpoint blockade, T cell costimulation, Neutrophils, innate immunity
Breast cancer, cryoablation, checkpoint inhibition, early-stage, ipilimumab, nivolumab, resectable